Stellus Capital's Q2 net investment income per share falls
Stellus Capital's Q2 net investment income per share falls
Overview
U.S. business development company reported fiscal Q2 net investment income per share fell yr/yr
Company repurchased 274,343 shares under buyback program during fiscal Q2
Net asset value per share remained steady
Result Drivers
LOWER INVESTMENT INCOME - Co said investment income fell to $22.3 mln from $25.7 mln in the prior yr qtr, mainly due to lower interest income from portfolio investments
HIGHER REALIZED LOSSES - Co reported net realized losses on investments of $7.2 mln in Q2, up from $0.9 mln a yr ago
NET PORTFOLIO REDUCTION - Repayments of $49 mln exceeded new investments of $18 mln, resulting in a smaller investment portfolio
Company press release: ID:nPnbwDlqKa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Net Asset Value Per Share |
| $12.80 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the closed end funds peer group is "hold"
Wall Street's median 12-month price target for Stellus Capital Investment Corp is $11.00, about 29.9% above its August 10 closing price of $8.47
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 9 three months ago
Reuters Recommended Reads
Aug 10 - Crescent Capital BDC Q2 net investment income falls due to Logan JV investment
Aug 10 - Kayne Anderson BDC Q2 net investment income dips, NAV falls
Aug 10 - PennantPark Floating Rate Capital Q3 NAV per share falls
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Stellus Capital Investment
See all newsStellus Capital's Q2 net investment income per share falls
Brief: Stellus Capital Management Announces Final Close Of Stellus Credit Fund IV
Brief: Stellus Capital Investment Corporation Reports Results For Its First Fiscal Quarter
Stellus Capital Investment Q1 net investment income falls
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics